Wattmo C

References (22)

Title : Differences in Dementia Care Between Swedish-Born and Foreign-Born from Countries with Different Country Level Socioeconomic Position: A Nationwide Register-Based Study - Lindgren_2021_J.Alzheimers.Dis__
Author(s) : Lindgren E , Sorenson J , Wattmo C , Kreholt I , Nagga K
Ref : J Alzheimers Dis , : , 2021
Abstract :
PubMedSearch : Lindgren_2021_J.Alzheimers.Dis__
PubMedID: 34657886

Title : Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease - Wattmo_2020_BMC.Neurol_20_10
Author(s) : Wattmo C , Blennow K , Hansson O
Ref : BMC Neurol , 20 :10 , 2020
Abstract :
PubMedSearch : Wattmo_2020_BMC.Neurol_20_10
PubMedID: 31918679

Title : Short-Term Response to Cholinesterase Inhibitors in Alzheimer's Disease Delays Time to Nursing Home Placement - Wattmo_2018_Curr.Alzheimer.Res_15_905
Author(s) : Wattmo C , Londos E , Minthon L
Ref : Curr Alzheimer Res , 15 :905 , 2018
Abstract :
PubMedSearch : Wattmo_2018_Curr.Alzheimer.Res_15_905
PubMedID: 29732972

Title : Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years - Wattmo_2017_Alzheimers.Res.Ther_9_70
Author(s) : Wattmo C , Wallin AK
Ref : Alzheimers Res Ther , 9 :70 , 2017
Abstract :
PubMedSearch : Wattmo_2017_Alzheimers.Res.Ther_9_70
PubMedID: 28859660

Title : Early-versus Late-Onset Alzheimer Disease: Long-Term Functional Outcomes, Nursing Home Placement, and Risk Factors for Rate of Progression - Wattmo_2017_Dement.Geriatr.Cogn.Dis.Extra_7_172
Author(s) : Wattmo C , Wallin AK
Ref : Dement Geriatr Cogn Dis Extra , 7 :172 , 2017
Abstract :
PubMedSearch : Wattmo_2017_Dement.Geriatr.Cogn.Dis.Extra_7_172
PubMedID: 28626471

Title : Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy - Wattmo_2016_Alzheimers.Res.Ther_8_7
Author(s) : Wattmo C , Minthon L , Wallin AK
Ref : Alzheimers Res Ther , 8 :7 , 2016
Abstract :
PubMedSearch : Wattmo_2016_Alzheimers.Res.Ther_8_7
PubMedID: 26883213

Title : Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease: a prospective, observational study of factors affecting survival time from admission to death - Wattmo_2016_BMC.Neurol_16_156
Author(s) : Wattmo C , Londos E , Minthon L
Ref : BMC Neurol , 16 :156 , 2016
Abstract :
PubMedSearch : Wattmo_2016_BMC.Neurol_16_156
PubMedID: 27581368

Title : Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services - Wattmo_2015_Dement.Geriatr.Cogn.Disord_40_297
Author(s) : Wattmo C , Londos E , Minthon L
Ref : Dementia & Geriatric Cognitive Disorders , 40 :297 , 2015
Abstract :
PubMedSearch : Wattmo_2015_Dement.Geriatr.Cogn.Disord_40_297
PubMedID: 26335053

Title : Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services - Wattmo_2014_Clin.Interv.Aging_9_1951
Author(s) : Wattmo C , Londos E , Minthon L
Ref : Clin Interv Aging , 9 :1951 , 2014
Abstract :
PubMedSearch : Wattmo_2014_Clin.Interv.Aging_9_1951
PubMedID: 25484578

Title : Risk Factors That Affect Life Expectancy in Alzheimer's Disease: A 15-Year Follow-Up - Wattmo_2014_Dement.Geriatr.Cogn.Disord_38_286
Author(s) : Wattmo C , Londos E , Minthon L
Ref : Dementia & Geriatric Cognitive Disorders , 38 :286 , 2014
Abstract :
PubMedSearch : Wattmo_2014_Dement.Geriatr.Cogn.Disord_38_286
PubMedID: 24992891

Title : Response to cholinesterase inhibitors affects lifespan in Alzheimer inverted question marks disease - Wattmo_2014_BMC.Neurol_14_173
Author(s) : Wattmo C , Londos E , Minthon L
Ref : BMC Neurol , 14 :173 , 2014
Abstract :
PubMedSearch : Wattmo_2014_BMC.Neurol_14_173
PubMedID: 25213579

Title : Prediction models for assessing long-term outcome in Alzheimer's disease: a review - Wattmo_2013_Am.J.Alzheimers.Dis.Other.Demen_28_440
Author(s) : Wattmo C
Ref : Am J Alzheimers Dis Other Demen , 28 :440 , 2013
Abstract :
PubMedSearch : Wattmo_2013_Am.J.Alzheimers.Dis.Other.Demen_28_440
PubMedID: 23689074

Title : Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application - Wattmo_2013_Alzheimers.Res.Ther_5_2
Author(s) : Wattmo C , Jedenius E , Blennow K , Wallin AK
Ref : Alzheimers Res Ther , 5 :2 , 2013
Abstract :
PubMedSearch : Wattmo_2013_Alzheimers.Res.Ther_5_2
PubMedID: 23286718

Title : Progression of mild Alzheimer's disease: knowledge and prediction models required for future treatment strategies - Wattmo_2013_Alzheimers.Res.Ther_5_44
Author(s) : Wattmo C , Wallin AK , Minthon L
Ref : Alzheimers Res Ther , 5 :44 , 2013
Abstract :
PubMedSearch : Wattmo_2013_Alzheimers.Res.Ther_5_44
PubMedID: 24099236

Title : A longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy - Wattmo_2013_Clin.Interv.Aging_8_329
Author(s) : Wattmo C , Paulsson E , Minthon L , Londos E
Ref : Clin Interv Aging , 8 :329 , 2013
Abstract :
PubMedSearch : Wattmo_2013_Clin.Interv.Aging_8_329
PubMedID: 23682212

Title : Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort - Wattmo_2012_BMC.Neurol_12_134
Author(s) : Wattmo C , Wallin AK , Minthon L
Ref : BMC Neurol , 12 :134 , 2012
Abstract :
PubMedSearch : Wattmo_2012_BMC.Neurol_12_134
PubMedID: 23126532

Title : Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting - Wallin_2011_Neuropsychiatr.Dis.Treat_7_565
Author(s) : Wallin AK , Wattmo C , Minthon L
Ref : Neuropsychiatr Dis Treat , 7 :565 , 2011
Abstract :
PubMedSearch : Wallin_2011_Neuropsychiatr.Dis.Treat_7_565
PubMedID: 22003296

Title : Predictors of long-term cognitive outcome in Alzheimer's disease - Wattmo_2011_Alzheimers.Res.Ther_3_23
Author(s) : Wattmo C , Wallin AK , Londos E , Minthon L
Ref : Alzheimers Res Ther , 3 :23 , 2011
Abstract :
PubMedSearch : Wattmo_2011_Alzheimers.Res.Ther_3_23
PubMedID: 21774798

Title : Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment - Wattmo_2011_Gerontologist_51_17
Author(s) : Wattmo C , Wallin AK , Londos E , Minthon L
Ref : Gerontologist , 51 :17 , 2011
Abstract :
PubMedSearch : Wattmo_2011_Gerontologist_51_17
PubMedID: 20562471

Title : A Quick Test of cognitive speed is sensitive in detecting early treatment response in Alzheimer's disease - Palmqvist_2010_Alzheimers.Res.Ther_2_29
Author(s) : Palmqvist S , Minthon L , Wattmo C , Londos E , Hansson O
Ref : Alzheimers Res Ther , 2 :29 , 2010
Abstract :
PubMedSearch : Palmqvist_2010_Alzheimers.Res.Ther_2_29
PubMedID: 20950460

Title : Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting - Wattmo_2008_Dement.Geriatr.Cogn.Disord_26_203
Author(s) : Wattmo C , Hansson O , Wallin AK , Londos E , Minthon L
Ref : Dementia & Geriatric Cognitive Disorders , 26 :203 , 2008
Abstract :
PubMedSearch : Wattmo_2008_Dement.Geriatr.Cogn.Disord_26_203
PubMedID: 18769065

Title : Five-year outcome of cholinergic treatment of Alzheimer's disease: early response predicts prolonged time until nursing home placement, but does not alter life expectancy - Wallin_2004_Dement.Geriatr.Cogn.Disord_18_197
Author(s) : Wallin AK , Gustafson L , Sjogren M , Wattmo C , Minthon L
Ref : Dementia & Geriatric Cognitive Disorders , 18 :197 , 2004
Abstract :
PubMedSearch : Wallin_2004_Dement.Geriatr.Cogn.Disord_18_197
PubMedID: 15211076